Page 14 - Nora Kronig News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Secret discounts leave patients at drugmakers’ mercy Some 63% of the drugs that received some kind of discount were cancer drugs. Keystone / Laurent Gillieron A new study by the University of Zurich has found that using confidential discounts on cancer and other drugs does little to make them available faster and at more affordable prices. This comes amid debate over a plan to keep more drug prices under lock and key in Switzerland. This content was published on February 19, 2021 - 11:00 February 19, 2021 - 11:00 Jessica Davis Plüss Jessica covers the good, the bad, and the ugly when it comes to big global companies and their impact in Switzerland and abroad. She’s always looking for a Swiss connection with her native San Francisco and will happily discuss why her hometown has produced some of the greatest innovations but can’t seem to solve its housing crisis.

United kingdomPatrick durischMerck keytrudaAdrian lobsigerRyan tandjungKerstin vokingerNora kronigWorld health assemblyWorld health organizationUniversity of zurichSwitzerland thisHodgkin lymphomaSwiss federal commissionerData protectionHealthcare policyஒன்றுபட்டது கிஂக்டம்